克莱姆生物 CLYM
$10.29 +$1.42 (+16.01%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $10.34 +0.49%
开盘$9.05
昨收$8.87
当日区间$8.84 – $10.33
成交量1.14M
市值$604.42M
市盈率（TTM）–
股息率–
CLYM 相关新闻
匹配 Climb Bio 或代码 CLYM 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Climb Bio(CLYM.US) With Buy Rating, Raises Target Price to $30 正面
- Truist Financial Maintains Climb Bio(CLYM.US) With Buy Rating
- A Quick Look at Today's Ratings for Climb Bio(CLYM.US), With a Forecast Between $25 to $40
- B. Riley Securities Maintains Climb Bio(CLYM.US) With Buy Rating, Raises Target Price to $30 正面
- RBC Capital Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $23
- Oppenheimer Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $18
- Truist Financial Maintains Climb Bio(CLYM.US) With Buy Rating, Announces Target Price $25
- BTIG Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $20
- RBC Capital Initiates Climb Bio(CLYM.US) With Buy Rating, Announces Target Price $23
- H.C. Wainwright Maintains Climb Bio(CLYM.US) With Buy Rating, Raises Target Price to $24 正面
- Wedbush Maintains Climb Bio(CLYM.US) With Buy Rating, Announces Target Price $20
- William Blair Maintains Climb Bio(CLYM.US) With Buy Rating
- Truist Financial Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $25
- Piper Sandler Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $23
- Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI) and Climb Bio (CLYM)
暂无评论——快来第一个聊聊 CLYM。